Satya Saxena
Head, Global Proteomics Eisai
Satya Saxena is the Director of Global Proteomics and Translational Medicine at Eisai. Responsible for overseeing the company’s proteomics and translational medicine initiatives, Saxena brings a wealth of experience to the role, having previously served as a Senior Consultant at Johns Hopkins Bayview Medical Center’s Department of Neurology. Saxena holds a Master of Science degree from Delhi University, underscoring his commitment to the field of pharmaceutical research and development
Seminars
Thursday 5th February 2026
Round Table Discussion: Unlocking Greater Understanding of the Proteome Through Accurate Analysis of Post-Translational Modifications
12:15 pm
- Capturing rare PTMs including tyrosine phosphorylation, glycosylation, and ubiquitination
- Overcoming limitations of instrument sensitivity to detect PTMs from limited samples and draw meaningful biomedical conclusions
- Evaluating the importance and feasibility of analyzing PTMs and selecting the appropriate instruments and workflows to do so
Thursday 5th February 2026
Panel Discussion: Establishing a Consensus on Proteomics Methodologies & Data Sharing to Enable Reproducible Analysis & Reliable Interpretation of Data
2:00 pm
- Defining robust, standardized proteomics methodologies, from sample collection and analysis to statistical protocols and generation of biomedical conclusions
- Developing a collaborative database to facilitate secure data visualization and sharing, maximizing the impact of available data
- Establishing collaborative projects amongst consortiums, academia, and industry to utilize existing datasets and generate a deeper understanding of proteomics to direct therapeutic development
Wednesday 4th February 2026
Combining Mass Spectrometry & Alternative Proteomics Platforms to Achieve Optimized Coverage & Throughput for Rapid, Comprehensive Proteomic Analysis
12:00 pm
- Demonstrating the benefits of utilizing mass spectrometry and other proteomics platforms, drawing on the advantages of multiple technologies to unlock greater insights
- Allocating budgets and managing resources effectively to strategically leverage multiple proteomics platforms to achieve maximum insights from patient data
- Deep diving into data from a drug discovery breakthrough made possible with proteomics
Thursday 5th February 2026
Chair’s Opening Remarks
8:50 am
Thursday 5th February 2026
Chair’s Closing Remarks
3:15 pm
